Fig. 6From: Comparing the benefits of chemoradiotherapy and chemotherapy for resectable stage III A/N2 non-small cell lung cancer: a meta-analysisForest plot comparing progression-free survival at 2, 4, and 6 years in patients who received induction chemotherapy or induction chemoradiotherapyBack to article page